During the past decade, Instituto Medico de Alta Complejidad San Isidro conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Instituto Medico de Alta Complejidad San Isidro" are "Rheumatoid Arthritis" (1 trials) and "Systemic Lupus Erythematosus (SLE)" (1 trials). Many other conditions were trialed in "Instituto Medico de Alta Complejidad San Isidro" in a lesser frequency.

Most popular intervention types in "Instituto Medico de Alta Complejidad San Isidro" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Baricitinib" (1 trials), "Placebo" (1 trials), "Placebo for Rozibafusp Alfa" (1 trials) and "Rozibafusp Alfa" (1 trials). Other intervention names were less common.

The vast majority of trials in "Instituto Medico de Alta Complejidad San Isidro" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Instituto Medico de Alta Complejidad San Isidro". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Instituto Medico de Alta Complejidad San Isidro, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Instituto Medico de Alta Complejidad San Isidro, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".